Sign in

CIK 0001504776

  • Large accelerated filer

Warby Parker Inc.

Sign in to watch
Ticker
WRBY
Exchange
NYSE
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
800423634
Phone
+1 646-847-7215
Business address
233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
Former names
JAND, Inc.
  1. 4 Open-market sale Director sold 6,000 shares at $23.56 ($141,360)
  2. 4 Planned sale Co-Chief Executive Officer sold 50,000 shares at $25.11 ($1,255,500)
  3. 4 Planned sale Co-Chief Executive Officer sold 50,000 shares at an average $24.21 ($1,210,420)
  4. 4 Planned sale Co-Chief Executive Officer sold 75,000 shares at an average $24.27 ($1,820,120)
  5. 4 Planned sale Co-Chief Executive Officer sold 50,000 shares at $22.04 ($1,102,000)
  6. 4 Grant or award Director acquired 12,020 shares (grant or award)
  7. 4 Grant or award Director acquired 12,020 shares (grant or award)
  8. 4 Grant or award Director acquired 17,362 shares (grant or award)
  9. 4 Grant or award Director acquired 12,020 shares (grant or award)
  10. 4 Grant or award Director acquired 16,026 shares (grant or award)
  11. 4 Grant or award Director acquired 16,026 shares (grant or award)
  12. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 5,430 shares (to pay taxes)
  13. 4 Shares withheld for taxes Co-Chief Executive Officer gave up 5,430 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 16,692 shares (to pay taxes)
  15. 4 Gift Director gave 1,519,661 shares (gift)
  16. 4 Open-market sale Director sold 33,073 shares at $19.90 ($658,153)
  17. 4 Other disposition Director disposed of 5,656,571 shares (other)
  18. 4 Open-market sale Chief Financial Officer sold 11,684 shares at $23.52 ($274,808)
  19. 4 Planned sale Co-Chief Executive Officer sold 202,968 shares at an average $23.51 ($4,772,513)
  20. 4 Planned sale Co-Chief Executive Officer sold 177,967 shares at an average $24.26 ($4,317,542)

Page 4 of 13 · 260 filings